Bente Magny Bergersen

     

    Publications 2011

    Brandsaeter BJ, Pillgram M, Berild D, Kjekshus H, Kran AM, Bergersen BM (2011)
    Hospitalised patients with suspected 2009 H1N1 influenza A in a hospital in Norway, July - December 2009
    BMC Infect Dis, 11, 75
    DOI 10.1186/1471-2334-11-75, PubMed 21435254

    Publications 2009

    Skeie L, Bugge H, Negaard A, Bergersen BM (2009)
    Large particle hyaluronic acid for the treatment of facial lipoatrophy in HIV-positive patients: 3-year follow-up study
    HIV Med, 11 (3), 170-7
    DOI 10.1111/j.1468-1293.2009.00761.x, PubMed 19780861

    Publications 2006

    Bergersen BM (2006)
    Cardiovascular risk in patients with HIV Infection: impact of antiretroviral therapy
    Drugs, 66 (15), 1971-87
    DOI 10.2165/00003495-200666150-00006, PubMed 17100407

    Bergersen BM, Schumacher A, Sandvik L, Bruun JN, Birkeland K (2006)
    Important differences in components of the metabolic syndrome between HIV-patients with and without highly active antiretroviral therapy and healthy controls
    Scand J Infect Dis, 38 (8), 682-9
    DOI 10.1080/00365540500361302, PubMed 16857615

    Publications 2005

    Bergersen BM, Sandvik L, Ellingsen I, Bruun JN (2005)
    Lipoatrophic men 44 months after the diagnosis of lipoatrophy are less lipoatrophic but more hypertensive
    HIV Med, 6 (4), 260-7
    DOI 10.1111/j.1468-1293.2005.00305.x, PubMed 16011531

    Bergersen BM, Tonstad S, Sandvik L, Bruun JN (2005)
    Low prevalence of high-density lipoprotein cholesterol level < 1 mmol/L in non-nucleoside reverse transcriptase inhibitor recipients
    Int J STD AIDS, 16 (5), 365-9
    DOI 10.1258/0956462053888808, PubMed 15949067

    Publications 2004

    Bergersen BM, Sandvik L, Bruun JN (2004)
    Body composition changes in 308 Norwegian HIV-positive patients
    Scand J Infect Dis, 36 (3), 186-91
    DOI 10.1080/00365540410019273, PubMed 15119363

    Bergersen BM, Sandvik L, Bruun JN, Tonstad S (2004)
    Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjects
    Eur J Clin Microbiol Infect Dis, 23 (8), 625-30
    DOI 10.1007/s10096-004-1177-6, PubMed 15322938

    Publications 2003

    Bergersen BM, Sandvik L, Dunlop O, Birkeland K, Bruun JN (2003)
    Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naïve and HIV-negative controls: results from a Norwegian study of 721 patients
    Eur J Clin Microbiol Infect Dis, 22 (12), 731-6
    DOI 10.1007/s10096-003-1034-z, PubMed 14610658

    Page visits: 1976